This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


Could novel immune cell therapy combat hepatitis B infections?

T cell
Credit: Pixabay/CC0 Public Domain

Chronic infection with the hepatitis B virus (HBV) causes progressive liver problems, and eradication of the virus remains a formidable challenge.

However, new research in FEBS Letters indicates that treatment that boosts the effects of immune cells called stem cell memory T cells (TSCMs) may be a promising strategy for combating HBV.

In the study, investigators identified TSCMs in patients with chronic HBV infection and analyzed their effects in a mouse model of HBV. After introducing TSCMs from patients into the mice, the immune cells differentiated into cytotoxic T cells and activated a strong response that resulted in the elimination of HBV-infected liver cells. Therefore, augmenting patients' TSCMs may help the immune system overcome the virus.

"Our hepatitis model may reveal how TSCMs differentiate into cytotoxic T cells and uncover the fate of differentiated T cells. Such information could greatly advance future research on T cell-based therapies," said corresponding author Hiromi Abe-Chayama, Ph.D., of Hiroshima University, in Japan.

More information: Hepatitis B virus-specific human stem cell memory T cells differentiate into cytotoxic T cells and eradicate HBV-infected hepatocytes in mice, FEBS Letters (2024). DOI: 10.1002/1873-3468.14842 , … 1002/1873-3468.14842

Journal information: FEBS Letters
Provided by Wiley
Citation: Could novel immune cell therapy combat hepatitis B infections? (2024, April 10) retrieved 21 July 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Boosting stem cell activity can enhance immunotherapy benefits


Feedback to editors